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Intracellular Free Zinc Ion Increase Triggers Hyperglycemia-Induced
Cardiomyocyte Dysfunction through Endoplasmic Reticulum Stress
Erkan Tuncay, Figen Amber Cicek, Aysegul Toy, Belma Turan.
Biophysics, Ankara University School of Medicine, Ankara, Turkey.
Intracellular free Zn2þ concentration, (Zn2þ)i is less than one nanomolar in
resting cardiomyocytes. Very little is known about mechanisms controlling
(Zn2þ)i distribution and variations during cardiac function although in vitro
oxidant exposures to cardiomyocytes caused 30-fold increase in (Zn2þ)i but
only 2-fold in (Ca2þ)i while thesewere 2-fold and 1.2-fold under hyperglycemia,
respectively. Since it has been mentioned that Zn2þ homeostasis is involved in
unfolded protein response (endoplasmic reticulum stress, ERS) under salt stress,
we aimed to investigate whether a hyperglycemia-induced increased level of
basal (Zn2þ)i can trigger an ERS, which in turn induces marked cardiomyocyte
dysfunction.Whenwe enforced Zn2þ influx into cytosol by using zinc ionophore
pyrithione (ZnPT), mechanical and electrical activities of cardiomyocytes
impaired in a concentration-dependent manner, similar to hyperglycemia. Incu-
bation of cardiomyocytes with ZnPT exerted also hyperphosphorylation in
RyR2, PKA, and CaMKII in a concentration-dependent manner, again similar
to hyperglycemia. The levels of some ERS chaperon proteins and ERS-
mediated apoptosis marker proteins (Calregulin, GRP 78, Bcl-2 and PUMA)
were also examined and compared in between ZnPT-incubated cardiomyocytes
and STZ-diabetic rat cardiomyocytes. The chaperon protein levels were found to
be increased in diabetics and also in ZnPT-incubated ones in a concentration
dependent-manner.We also observed a similar parallel correlation between these
two-group experiments for anti-apoptotic protein Bcl-2 and apoptotic one
PUMA. Taken into consideration diabetes-induced cardiac dysfunction due to,
in part, increased basal (Zn2þ)i and in vitro increased (Zn
2þ)i-induced cardio-
myocyte dysfunction present a possible triggering role of increased (Zn2þ)i in
hyperglycemia-induced cardiomyocyte dysfunction through ERS.
(Supported by grant from TUBITAK SBAG-111S042)
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KD Channel-Interacting Protein 2 Deficient mice have a Rate Dependent
Prolongation of Left Ventricular CA2D Transients
Soren Grubb1, Gary L. Aistrup2, Soren-Peter Olesen1,
Tobias Speerschneider1, Kirstine Calloe1, Morten B. Thomsen1.
1University of Copenhagen, Copenhagen N, Denmark, 2Northwestern
University, Chicago, IL, USA.
In the heart, Kþ channel-interacting protein 2 (KChIP2) stabilizes Kv4
channels in the membrane resulting in larger transient outward potassium
currents (Ito). Recently it has been demonstrated that KChIP2 also enhances
Cav1.2 and that the KChIP2-/- mouse has reduced inward L-type Ca2þ current.
In this study, we test the impact of KChIP2-/- on cardiac contraction and on
underlying Ca2þ transients.
Through ultrasound examination, we found comparable left ventricular ejection
fraction and fractional shortening in the heart of wild-type (WT) and KChIP2-/-
mice, indicating that the function of the left ventricle was not impaired despite
reduced L-type Ca2þ current. Confocal line scan Ca2þ imaging was performed
using the Cal-520TM fluorophore. Whole-cell Ca2þ transients were recorded
from disaggregated left ventricular cardiomyocytes at 37C, field stimulated at
cycle lengths between 80 and 1000 ms. A decrease in the relative peak of the
Ca2þ transient was found in KChIP2-/- versus WT (0.5850.06 vs. 0.7150.07
F/F0, P<0.05) and the time to 50% decay of the transient was prolonged
(13355 vs. 12153 ms, P<0.05). These differences were rate-dependent and
diminished at cycle lengths shorter than 1000ms. However, at the fastest pacing
rate more cardiomyocytes were alternating in KChIP2-/- compared with WT
(cycle length: 80 ms;WT: 12/18, KChIP2-/-: 23/23). The fractional Ca2þ release
was not different between the two genotypes, suggesting that the differences in
Ca2þ transients are not a result of differential SR load.
In conclusion, although cardiac contraction is not impaired in the KChIP2-/-
mouse, some abnormal Ca2þ handling is apparent in individual KChIP2-/-
cardiomyocytes, including a higher propensity to develop Ca2þ transient alter-
nans. If this is manifested significantly at the tissue level, it could contribute to
the development of repolarization gradients across the myocardium.
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Calcium Handling in Experimental Models of Doxorubicin and
Radiation-Induced Cardiotoxicity
Anna Llach1, Marianne Mazevet1, Virginie Monceau2, Philippe Mate´o1,
Jean-Pierre Be´nitah1, Marie-Catherine Vozenin3, Eric Morel1,
Ana Marı´a Go´mez1.
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France, 3Radio-oncology Laboratory, CHUV, Lausanne, Switzerland.As a result of more effective therapies, more patients recover from cancer.
However, often they develop cardiotoxicity manifested, among others, as
heart failure. Doxorubicin (Dox), a widely used and highly effective cancer
chemotherapeutic agent, and radiation therapy (RT), when directed to the
thorax, can affect cardiac function. Because intracellular Ca2þ fluxes underlie
cardiac function, we investigated intracellular Ca2þ handling in mice treated
with doxorubicin (Dox) or chest radiotherapy (RT). 12 weeks old, C57BL/6
male mice received 3 i.v. injections of 4 mg/Kg Dox each, reaching a cumu-
lative dose of 12mg/kg of Dox. Data was obtained at 2, 6 and 15 weeks after
last injection. RT-treated mice were locally irradiated with 2 and 16Gy local-
ized to the heart, and experiments performed 20 and 50 weeks after irradia-
tion. M-mode Echocardiography showed a significant reduction of the
ejection fraction (EF) at 15w after last injection of Dox. Consistently, the
amplitude of [Ca2þ]i transients was decreased (F/F0: 4.1050.25, n=11 con-
trol cells, vs 3.2250.14, n=15 Dox, p<0.01) and slowed (Tau in ms:
138.9856.17, n=11 control vs 169.63511.91, n=15 Dox, p<0.05) at 15w
with a significant increase in the frequency of Ca2þ sparks, but without
changes on the SR Ca2þ content. RT induced a LV enlargement associated
with a significant reduction of EF in low and high dose irradiated mice group
at both time lapses. However, Ca2þ handling was minimally affected by RT.
After 50w of 16Gy RT, we observed a faster decay of [Ca2þ]i transients with
unaltered amplitude and SR Ca2þ content. Our results indicate that the
depressed cardiac function after Dox treatment involves [Ca2þ]i transient
reduction, while in RT-induced cardiotoxicity the Ca2þ alteration may not
be involved likewise.
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Mechanisms of Anthracycline-Induced Dysfunction of Calcium Handling
Proteins in the Heart
Amy D. Hanna1, Alex Lam1, Angela F. Dulhunty1, Nicole A. Beard2.
1Australian National University, Canberra, Australia, 2University of
Canberra, Canberra, Australia.
Anthracyclines are powerful chemotherapy agents, whose use is limited due
to the onset of potentially fatal cardiotoxicity which includes arrhythmo-
genesis and heart failure. Several proteins important in intracellular Ca2þ sig-
nalling have been identified as drug binding targets, including the cardiac
ryanodine receptor Ca2þ release channel (RyR2), the Ca2þ binding protein
calsequestrin (CSQ2) and the Sarco/Endoplasmic Reticulum Ca-ATPase
(SERCA2a). The effects of the drug metabolites have been poorly character-
ized but are believed to be important in the devastating cardiac effects of these
drugs.
The functional effect of doxorubicin and its metabolite, doxorubicinol on
RyR2 was assessed by adding clinically relevant drug concentrations to single
RyR2 channels in lipid bilayers. Both drugs caused biphasic modulation
of RyR2 activity where there was an early increase in channel activity
followed by a later, inhibitory phase. RyR2 channel activation, but not inhi-
bition, could be reversed by drug washout, typical of a ligand binding effect.
Conversely, the irreversible nature of the inhibitory effect suggested a non-
ligand binding effect. Treatment with doxorubicin/doxorubicinol reduced
the number of thiols on RyR2, indicative of drug-induced thiol oxidation.
Additionally, doxorubicinol abolished the response of RyR2 to changes in
luminal Ca2þ. Further experiments revealed that the loss of luminal Ca2þ
sensing was due to an interaction between doxOL and CSQ2. Finally, we
found that doxorubicinol inhibits SERCA2a Ca2þ uptake into SR vesicles
and that this was prevented by pretreatment with DTT. These results provide
novel insight into the cellular mechanisms of anthracyclines. We suggest that
by targeting multiple Ca2þ handling proteins in cardiac muscle, anthracy-
clines severely disturb cardiomyocyte Ca2þ homeostasis and that these effects
have an important role in the onset of anthracycline-mediated arrhythmia and
heart failure.
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Predictive Drug Toxicity Profiling using a New Mode of Calcium Signal
Analysis in Human Es-Derived Cardiomyocytes
Kimberley J. Lewis, Sarah A. Marsh, Christopher H. George.
Wales Heart Research Institute, Cardiff University, United Kingdom.
Contemporary drug screening platforms often fail to resolve hazards related to
chronic toxicity. Many drugs induce a defective homeostatic state, which may
acutely appear ‘normal’, but the chronicity of which provokes phenotypic
dysfunction (latent toxicity). We showed that abnormal Ca2þ signals can be
embedded within perceptibly normal steady-state Ca2þ cycling. In order to
expose these hidden Ca2þ patterns, we developed methods to decrypt intra-
and inter-cellular Ca2þ signals in individual cardiomycytes and in multicellular
populations. In this proof-of-concept study, we used confocal imaging and
pattern analysis of Ca2þ handling in spontaneously contractile Cytiva
114a Sunday, February 16, 2014ES-derived cardiomyocytes to identify specific perturbations in the Ca2þ signal
‘fingerprint’ evoked by a panel of CV-active drugs (1nM to 100mM). We calcu-
lated four indices that describe the spatial and temporal organisation of drug-
evoked Ca2þ cycling: 1) inter-transient noise (ITN), the amplitude variability
of Ca2þ signals occurring between Ca2þ transients; 2) peak regularity index
(PRI), a statistical assessment of Ca2þ transient peak-to-peak variability; 3)
height regularity index (HRI), the amplitude heterogeneity between successive
Ca2þ transients and 4) synchrony- the extent of synchronization of Ca2þ tran-
sients across the syncytia. These four parameters were integrated, together
with an assessment of cellular contractility, into a single non-biased safety
score. In operator-blinded analyses, the rank order of drug hazard was
confirmed as astemizole > flecainide > cisapride = sotalol > thioridazine >
valdecoxib >> nadolol = control. This assessment is remarkably similar to
the established hazard profile of these drugs. Our data support the utility of
this mechanistically agnostic framework for the rapid and discriminatory
evaluation of CV drug toxicity.
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A Novel Fluorescent Epac-Agonist Reveals Epac1 and Epac2 Subcellular
Localization in Cardiomyocytes
Laetitia Pereira1, Jeffrey Erickson1, Ju Chen2, Donald M. Bers1.
1Pharmacology, UC Davis, Davis, CA, USA, 2Medicine, UC San Diego,
La Jolla, CA, USA.
Epac (Exchange proteins directly activated by cAMP) exist in two isoforms,
Epac1 and Epac2. In cardiomyocytes, evidence is building that Epac2 medi-
ates CaMKII and ryanodine receptor related arrhythmia whereas Epac1 over-
expression leads to cardiac hypertrophy. This suggests potential subcellular
localization differences for Epac1 and 2, but localization information in
myocytes has been limited by antibody specificity. Here, we used a novel
fluorescent cAMP-derivate Epac agonist 8-[Pharos-575]-2’-O-Me-cAMP
(F-O-Me-cAMP) to identify Epac1 and Epac2 cardiac localization. F-O-
Me-cAMP exhibits peak excitation at 543 nm and emission at 610 nm and
increases several-fold when bound to Epac. Its Epac specificity was verified
in double Epac1/Epac2 knockout mouse myocytes (DKO), and by competition
with the non-fluorescent Epac agonist, 8-CPT (Fluorescence= 1,6955162 for
F-O-Me-cAMP (n=13) vs. 394541 with 100 mM 8-CPT (n=20) and 439516
in DKO (n=52)). The apparent affinity of F-O-Me-cAMP (Kd) for Epac was
9.650.7 mM (n=14). F-O-Me-cAMP binding to PKA (a known cAMP target)
is excluded because of the DKO results above and its lack of effect on PKA
activity (assessed by a PKA-FRET-reporter) and a lack of effect of 100 mM
Rp-cAMP (a PKA specific activator) on F-O-Me-cAMP signals in cells.
Binding of 10 mM F-O-Me-cAMP in intact cells rose to a maximum with
t=30 min. Localization of F-O-Me-cAMP binding in Epac1-KO mice (i.e.
Epac2 location) was prominently T-tubular (tracking Di-8-ANEPPS), whereas
Epac1 distribution (in Epac2-KO cells) was non-striated and concentrated
around the nucleus. In conclusion, F-O-Me-cAMP is a valuable fluorescent
Epac-specific agonist. We conclude that Epac2 is T-tubular whereas Epac1
is more nuclear, which parallels their effects on Ca sparks and nuclear
signaling, respectively.
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Functionally Isolated Sarcoplasmic ReticulumModel: Intrinsic Regulation
of SR Ca2D Release and Tetracaine Effect
Marina C. Monteiro1, Rosana A. Bassani2, Jose´ W. Bassani1.
1DEB-FEEC, Universidade Estadual de Campinas, Campinas, SP, Brazil,
2CEB, Universidade Estadual de Campinas, Campinas, SP, Brazil.
The fraction of the sarcoplasmic reticulum (SR) Ca2þ content released at a
twitch (fractional release, FR) in cardiomyocytes is regulated by the L-type
Ca2þ current (ICa,L) and the SR Ca2þ content ([Ca2þ]SR). In the experimental
model of the functionally isolated SR (FISRM), cardiomyocytes are perfused
with Naþ, Ca2þ-free solution, which makes the cells unexcitable and thermo-
dynamically inhibits the sarcolemmal Naþ/Ca2þ exchanger. Intracellular free
Ca2þ concentration ([Ca2þ]i) was measured with fluo-3 and Ca2þ transients
due to SR release were evoked by 100 ms-long caffeine pulses. FISRM was
used to study the intrinsic relationship between FR and [Ca2þ]SR in the
absence of ICa,L, the physiological trigger for SR Ca2þ release. After SR
depletion by prolonged caffeine application, 1-20 electrical stimuli were
applied to attain different [Ca2þ]SR (from 55.3510.0 to 123.0510.3 mM).
The variation in total [Ca2þ] (D[Ca2þ]T) during transients was estimated
from [Ca2þ]i and Ca2þ buffering parameters. FR (D[Ca2þ]T/[Ca2þ]SR)
showed a non-linear relationship with [Ca2þ]SR (from 5.455.4 to
82.857.2%, p< 0.05), as previously observed when SR Ca2þ release was trig-
gered by ICa,L. This behavior was reproduced with a mathematical model of
FISRM, after inclusion of intra-SR and cytosolic Ca2þ buffers, which resulted
in more realistic simulations. In addition, FISRM was used to study the inhib-itory effect of tetracaine on FR. The tetracaine concentration that caused 50%
inhibition of FR (IC50) was 58.955.7 mM. The FISRM may be a useful
experimental model to investigate in intact cells the selective effects on SR
Ca2þ release of drugs that also affect sarcolemmal currents, such as tetracaine.
Support: CNPq.
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Fluorescence Signal Kinetics of a New Ca2D Probebound to Cardiac
Ryanodine Receptors Point to Micro-Domain Detection of Ca2D
Xiao-Hua Zhang, Lars Cleemann, Martin Morad.
Cardiac Signaling Center, University of South Carolina, Charleston,
SC, USA.
To probe the micro-domains of Ca2þ-signaling, we constructed a probe,
calstabi-cam, targeted to cardiac ryanodine receptors (RyR2) by FKBP12.6
(calstabin 2) incorporating calmodulin and EYFP as Ca2þ-sensor. 48-72h after
infection of cultured rat neonatal cardiomyocytes (rNCM), global measure-
ments of calstabi-cam fluorescence were accompanied by simultaneous
recordings of Ca2þ channel (ICa) and Na
þ/Ca2þ-exchanger (INCX) and
compared to measurements of fluo-4 Ca-transients. rNCMs continued sponta-
neous beating after dialysis with Csþ-based internal solutions (0.1-0.2mM
EGTA at 50mV) as they generated calstabi-cam fluorescence signals that
coincided with INCX oscillations, like those measured by fluo-4 that were
blocked by 10mM ryanodine. Activation of ICa (~5pA/pF) triggered slowly
relaxing Ca-transients of calstabi-cam fluorescence (DF/F0 = 0.11; n=14).
Similarly, short caffeine pulses also activated long lasting calstabi-cam signals
(-DF/F0=0.1550.012; n=28) accompanied by INCX (1.5750.13pA/pF; n=28).
Calstabi-cam signals activated by rapid Naþ withdrawal was significantly
delayed (~230ms) compared to those triggered by ICa (~13ms) or caffeine
(~35ms). Similar results were found in feline adult cardiac myocytes where
1mM Isoproterenol increased ICa significantly without enhancing the associ-
ated calstabi-cam transients. These results suggest that the new probe re-
sponds more effectively to Ca2þ that is released into dyadic clefts by RyR2
than by sarcolemmal Ca2þ influx via Na/Ca exchanger. The extremely slow
decay kinetics of Calstabi-cam signal is consistent with the notion that
[Ca2þ] in the dyadic cleft may rise to much higher values than those of
cytosol.
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Calcium-Induced Redox Microdimains at the ER-Mitochondrial Interface
David M. Booth1, Bala´zs Enyedi2, Miklo´s Geiszt2, Pe´ter Va´rnai3,
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Diverse interactions between Ca2þ and reactive oxygen species (ROS) signal-
ling are thought to exist and be of both physiological and pathophysiological
relevance. We hypothesized that ROS and Ca2þ interact locally at the ER-
mitochondrial interface to induce mitochondrial Ca2þ-overload and subse-
quent permeability transition. To test the relationship between ROS and
Ca2þ, we used genetically-encoded tools to selectively generate and measure
ROS at confined locations within HepG2 and MEF cells. Using Killer Red
(KR) targeted to the ER-mitochondrial interface or nucleus, we selectively
controled the oxidation of these compartments with illumination. When
KR was targetted to the ER-Mitochondrial interface, illumination caused
a >3-fold increase in cytoplasmic Ca2þ response to a low-dose IP3-linked
agonist as measured with fura 2, whereas illumination of the KR targeted
to the nucleus was ineffective. These data demonstrate that ROS generated
at the ER-mitochondrial interface are capable of sensitizing Ca2þ release,
whereas more distant ROS was not. To test if (patho)physiological conditioins
could oxidise the ER-mitochondrial interface in the same way, we utilized the
genetically-encoded ratiometric sensor HyPer and the redox de-sensitized
derivative SypHer to control for non-specific changes. These probes, targeted
to the ER-mitochondrial interface or nucleus, are positioned to assess redox
changes at a local level. When permeabilized MEF cells were subject to mito-
chondrial Ca2þ overload, a cyclosporine A-sensitive decrese in mitochondrial
membrane potential, consistent with permeability transition, was observed.
This was accompanied by a pronounced burst of H2O2 at the ER-
mitochondrial interface but not the nucleus. These data demonstrate that the
ER-mitocondrial interface may host a local redox microdomain and that
ROS generated at locations immediately apposed to Ca2þ-transport proteins,
such as the IP3 receptor, sensitize Ca2þ release whereas distant ROS did
not. These observations underline the critical role of spatial organization in
ROS-Ca2þ crosstalk in mitochondrial signalling.
